The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease.EBI
Temple University School Of Pharmacy
Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease.EBI
Kyoto University
Progress and developments in tau aggregation inhibitors for Alzheimer disease.EBI
Humboldt Universit£T Zu Berlin
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.EBI
Northwestern University
2-Styrylindolium based fluorescent probes visualize neurofibrillary tangles in Alzheimer's disease.EBI
Technische Universit£T Darmstadt
Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.EBI
TBA
Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils andß-amyloid plaques in Alzheimer's disease models.EBI
Technische Universit£T Darmstadt
Novel compounds for the treatment of neurodegenerative diseases: patent highlight.EBI
TBA
Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease.EBI
Kyoto University
(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.EBI
TBA